CAS-ViewAlert

View Alert




Originator:		MHRA Drug Alerts
From:		Himal Makwana
Issue date:		02-Mar-2020 09:59:24
This alert has been issued to:
		NHS Regional Offices NHS Foundation Trusts (England) - Medical Director NHS Trusts (England) - Medical Director Territorial CMOs in Northern Ireland, Scotland & Wales
		MHRA (Medicines) Drug Alerts (Various Recipients) Other contacts Independent Healthcare Providers (registered with CAS) Clinical Commissioning Groups NHS Foundation Trusts (England) - Chief Executive MHRA (Medicines) Drug Alerts - Non-NHS Recipients Regional Directors of Public Health Director of Public Health NHS Trusts (England) - Chief Executive GP - Locum NHS 111 and Out of hours providers Dispensing GP Practices GP Practices Primary Care Networks
Action category:		Class 2: Action within 48 hours
Title:		CLASS 2 DRUG ALERT, ACTION WITHIN 48 HOURS, AOP ORPHAN PHARMACEUTICALS AG, TETRABENAZINE 25MG TABLETS
Broadcast content:		AOP Orphan Pharmaceuticals AG is recalling all unexpired stock of the above batch of Tetrabenazine 25 mg tablets (from pharmacies and wholesalers) as a precautionary measure due to out of specification results for the assay, obtained during routine stability testing. Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts.
Additional information:		NHS England Regional Offices: please cascade this alert to Community Pharmacy and Dispensing GP Practices not yet registered with CAS. GP Practices: please note this alert is for Dispensing GP Practices only.
Alert reference:		EL (20)A/13
Attachments:		EL (20)A 13 Final.pdf
Cascade to:		#COMMUNITYPHARMACISTS# #DISPENSING GP# #HospitalPharmacy#